Paclitaxel neurotoxicity is triggered by epidermal EG5-dependent microtubule fasciculation and X-ROS formation

Sandra Rieger1, Chia-Jung Hsieh1, Cirrincione Anthony1

  • 1Department of Biology, University of Miami, Coral Gables, Florida 33146, USA.

Research Square
|September 2, 2025
PubMed

Insights

Paclitaxel causes nerve damage by disrupting microtubules in skin cells, leading to chemotherapy-induced peripheral neuropathy (CIPN). This mechanism, involving Eg5 kinesin, affects both healthy skin and cancer cells, posing a treatment challenge.

Area of Science:

  • Oncology
  • Neuroscience
  • Cell Biology

Background:

  • Taxanes are crucial chemotherapy drugs for cancer treatment.
  • Chemotherapy-induced peripheral neuropathy (CIPN) is a common, debilitating side effect.
  • The precise mechanisms underlying taxane-induced neurotoxicity are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which paclitaxel induces peripheral neuropathy.
  • To investigate the role of microtubule dynamics and specific proteins in taxane neurotoxicity.
  • To explore potential therapeutic strategies for mitigating CIPN.

Main Methods:

  • Utilized a cross-species approach including zebrafish, mice, human skin biopsies, and cell lines.
  • Investigated the interaction between paclitaxel, Eg5 kinesin, and microtubule stability.
  • Analyzed nuclear lamina integrity, reactive oxygen species (ROS) production, and gene expression (mmp13).

Main Results:

  • Paclitaxel induces microtubule fasciculation in epidermal keratinocytes via Eg5 kinesin.
  • This process deforms the nuclear lamina, leading to nuclear ROS (X-ROS) formation.
  • A conserved paclitaxel-Eg5-microtubule mechanism was identified in both healthy epidermis and cancer cells.

Conclusions:

  • Paclitaxel's neurotoxic effects stem from Eg5-mediated microtubule stabilization in keratinocytes, initiating CIPN.
  • The findings reveal a dual role of paclitaxel, impacting both cancer cells and healthy tissues.
  • Addressing this mechanism is critical for balancing anticancer efficacy and neurotoxic side effects.